Hyun Jae Cho

Mr. Hyun Jae Cho

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HCHyun Jae Cho
Hyun Jae Cho
MSMia Shu
Mia Shu
SBStefan Bekiranov
Stefan Bekiranov
CZChongzhi Zang
Chongzhi Zang
AZAidong Zhang
Aidong Zhang
Motivation: Despite the success of recent machine learning algorithms’ applications to survival analysis, their black-box nature hinders interpretability, which is arguably the most important aspect. Similarly, multi-omics data integration for survival analysis is often constrained by the underlying relationships and correlations that are rarely well understood. The goal of this work is to alleviate the interpretability problem in machine learning approaches for survival analysis and also demonstrate how multi-omics data integration improves survival analysis and pathway enrichment. We use meta-learning, a machine-learning algorithm that is trained on a variety of related datasets and allows quick adaptations to new tasks, to perform survival analysis and pathway enrichment on pan-cancer datasets. In recent machine learning research, meta-learning has been effectively used for knowledge transfer among multiple related datasets.Results: We use meta-learning with Cox hazard loss to show that the integration of TCGA pan-cancer data increases the performance of survival analysis. We also apply advanced model interpretability method called DeepLIFT (Deep Learning Important FeaTures) to show different sets of enriched pathways for multi-omics and transcriptomics data. Our results show that multi-omics cancer survival analysis enhances performance compared with using transcriptomics or clinical data alone. Additionally, we show a correlation between variable importance assignment from DeepLIFT and gene coenrichment, suggesting that genes with higher and similar contribution scores are more likely to be enriched together in the same enrichment sets.Availability and implementation: https://github.com/berkuva/TCGA-omics-integration.

23 January 2024 in Genes
Verified
Journal Article
Open access
PDF file
HCHyun Jae Cho
Hyun Jae Cho
ZWZhenjia Wang
Zhenjia Wang
YCYidan Cong
Yidan Cong
Stefan BekiranovStefan Bekiranov
Stefan Bekiranov
AZAidong Zhang
Aidong Zhang
CZChongzhi Zang
Chongzhi Zang
Characterization of gene regulatory mechanisms in cancer is a key task in cancer genomics. CCCTC-binding factor (CTCF), a DNA binding protein, exhibits specific binding patterns in the genome of cancer cells and has a non-canonical function to facilitate oncogenic transcription programs by cooperating with transcription factors bound at flanking distal regions. Identification of DNA sequence features from a broad genomic region that distinguish cancer-specific CTCF binding sites from regular CTCF binding sites can help find oncogenic transcription factors in a cancer type. However, the presence of long DNA sequences without localization information makes it difficult to perform conventional motif analysis. Here, we present DNAResDualNet (DARDN), a computational method that utilizes convolutional neural networks (CNNs) for predicting cancer-specific CTCF binding sites from long DNA sequences and employs DeepLIFT, a method for interpretability of deep learning models that explains the model’s output in terms of the contributions of its input features. The method is used for identifying DNA sequence features associated with cancer-specific CTCF binding. Evaluation on DNA sequences associated with CTCF binding sites in T-cell acute lymphoblastic leukemia (T-ALL) and other cancer types demonstrates DARDN’s ability in classifying DNA sequences surrounding cancer-specific CTCF binding from control constitutive CTCF binding and identifying sequence motifs for transcription factors potentially active in each specific cancer type. We identify potential oncogenic transcription factors in T-ALL, acute myeloid leukemia (AML), breast cancer (BRCA), colorectal cancer (CRC), lung adenocarcinoma (LUAD), and prostate cancer (PRAD). Our work demonstrates the power of advanced machine learning and feature discovery approach in finding biologically meaningful information from complex high-throughput sequencing data.

12 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAaron Gu
Aaron Gu
HCHyun Jae Cho
Hyun Jae Cho
NSNathan Sheffield
Nathan Sheffield
Functional genomics experiments, like ChIP-Seq or ATAC-Seq, produce results that are summarized as a region set. Many tools have been developed to analyze region sets, including computing similarity metrics to compare them. However, there is no way to objectively evaluate the effectiveness of region set similarity metrics. In this paper we present Bedshift , a command-line tool and Python API to generate new BED files by making random perturbations to an original BED file. Perturbed files have known similarity to the original file and are therefore useful to benchmark similarity metrics. To demonstrate, we used Bedshift to create an evaluation dataset of hundreds of perturbed files generated by shifting, adding, and dropping regions from a reference BED file. Then, we compared four similarity metrics: Jaccard score, coverage score, Euclidean distance, and cosine similarity. Our results highlight differences in behavior among these metrics, such as that Jaccard score is most sensitive to added or dropped regions, while coverage score is most sensitive to shifted regions. Together, we show that Bedshift is a useful tool for creating randomized region sets for a variety of uses. Availability: BSD2-licensed source code and documentation can be found at https://bedshift.databio.org .

21 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
HCHyun Jae Cho
Hyun Jae Cho
EXEric Xie
Eric Xie
AZAidong Zhang
Aidong Zhang
Stefan BekiranovStefan Bekiranov
Stefan Bekiranov
Single cell RNA sequencing (scRNA-seq) is a powerful approach which generates genome-wide gene expression profiles at single cell resolution. Among its many applications, it enables determination of the transcriptional states of distinct cell types in complex tissues, thereby allowing the precise cell type and set of genes driving a disease to be identified. However, scRNA-seq remains costly, and there are extremely limited samples generated in even the most extensive human disease studies. In sharp contrast, there is a wealth of publicly available bulk RNA-seq data, in which single cell and cell type information are effectively averaged. To further leverage this wealth of RNA-seq data, methods have been developed to infer the fraction of cell types from bulk RNA-seq data using single cell data to train models. Additionally, generative AI models have been developed to generate more of an existing scRNA-seq dataset. In this study, we develop an innovative framework that takes full advantage of powerful generative AI approaches and existing scRNA-seq data to generate representative scRNA-seq data from bulk RNA-seq. Our bulk to single cell variational autoencoder-based model, termed bulk2sc , is trained to deconvolve pseudo-bulk RNA-seq datasets back into their constituent single-cell transcriptomes by learning the specific distributions and proportions related to each cell type. We assess the performance of bulk2sc by comparing synthetically generated scRNA-seq to actual scRNA-seq data. Application of bulk2sc to large-scale bulk RNA-seq human disease datasets could yield single cell level insights into disease processes and suggest targeted scRNA-seq experiments.

1 January 2023
Verified
Book Chapter
Closed access
QSQiuling Suo
Qiuling Suo
HCHyun Jae Cho
Hyun Jae Cho
JCJingyuan Chou
Jingyuan Chou
Stefan BekiranovStefan Bekiranov
Stefan Bekiranov
CZChongzhi Zang
Chongzhi Zang
AZAidong Zhang
Aidong Zhang

20 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
HCHyun Jae Cho
Hyun Jae Cho
ZWZhenjia Wang
Zhenjia Wang
YCYidan Cong
Yidan Cong
Stefan BekiranovStefan Bekiranov
Stefan Bekiranov
AZAidong Zhang
Aidong Zhang
CZChongzhi Zang
Chongzhi Zang
Motivation Characterization of regulatory elements in DNA sequence is a key task in functional genomics. CTCF exhibits specific binding patterns in the genome of cancer cells and has a non-canonical function to facilitate oncogenic transcription program by cooperating with transcription factors bound at flanking distal regions. Identification of sequence motifs from a broad genomic region surrounding cancer-specific CTCF binding sites can help find active transcription factors in a cancer type. However, the long DNA sequences without localization information makes it difficult to perform conventional motif enrichment analysis. Results We present DNAResDualNet (DARDN), a computational method that utilizes convolutional neural networks (CNNs) coupled with feature discovery using DeepLIFT, for identifying DNA sequence features that can differentiate two sets of lengthy DNA sequences. Evaluation on DNA sequences associated with CTCF binding sites in T-cell acute lymphoblastic leukemia (T-ALL) and other cancer types demonstrates DARDN’s ability in classifying DNA sequences surrounding cancer-specific CTCF binding from control constitutive CTCF binding and identifying sequence motifs for transcription factors potentially active in each specific cancer type. We identified motifs for potential oncogenic transcription factors in T-ALL, acute myeloid leukemia (AML), breast cancer (BRCA), colorectal cancer (CRC), lung adenocarcinoma (LUAD), and prostate cancer (PRAD). Our work demonstrates the power of advanced machine learning and feature discovery approach in finding biologically meaningful information from complex DNA sequence data. Author summary We present DNAResDualNet (DARDN), a deep learning model designed for identifying DNA sequence motifs in long DNA sequences, particularly for revealing oncogenic transcription factors in various cancers. Building on our previous work (Fang et al., Genome Biol. 2020), which uncovered the non-canonical role of cancer-specific CTCF binding in oncogenesis, DARDN uses a dual convolutional neural network with residual connections and the DeepLIFT method to discern complex patterns in DNA. We successfully applied DARDN to identify unique sequence motifs in T-cell acute lymphoblastic leukemia and other cancers like AML, BRCA, CRC, LUAD, and PRAD, showcasing its capability in cancer genomics research. This work underscores the potential of deep learning in functional genomics, especially in interpreting biological data and discovering new insights in gene regulation and cancer genomics.